Physician profile
Ian Dworkin
NPI 1861810368
$18,944.38
in general payments reported to CMS, 2019-2025
20 companies · $2,333 in 2025
The $2,333 reported for 2025 was more than what 87% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,692 · 2020: $754 · 2021: $2,346 · 2022: $2,714 · 2023: $5,484 · 2024: $3,621 · 2025: $2,333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,158 · Travel and Lodging: $4,280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,158.34 |
| Travel and Lodging | $4,279.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $7,764.35 | 2019-2025 | Proclaim, Eterna, Infinity |
| Saluda Medical Americas, INC. | $2,724.14 | 2023-2025 | Evoke, Evoke Scs |
| Boston Scientific Corporation | $2,697.82 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Spinal Simplicity, LLC | $1,273.43 | 2022 | |
| Nevro Corp. | $877.65 | 2019-2024 | Senza |
| Nalu Medical, INC. | $557.23 | 2021-2025 | Nalu Neurostimulation System |
| Biotronik Nro, INC. | $508.81 | 2024-2025 | Prospera |
| Medtronic, INC. | $462.04 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Stimwave Technologies Incorporated | $386.70 | 2019-2021 | |
| Allergan, INC. | $309.44 | 2019-2020 | |
| Medtronic USA, INC. | $282.71 | 2019-2020 | |
| Globus Medical, INC. | $248.51 | 2025 | Senza |
| Electronic Waveform Lab, INC. | $241.56 | 2021-2022 | |
| Curonix LLC | $227.43 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Amgen INC. | $89.55 | 2019-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $81.64 | 2025 | Reactiv8 |
| Vertos Medical, INC. | $81.06 | 2022-2024 | Mild Device Kit |
| Merz North America, INC. | $60.26 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $49.88 | 2019 | |
| Merz Pharmaceuticals, LLC | $20.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Dworkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.